NOT, TARCISIO
 Distribuzione geografica
Continente #
NA - Nord America 18.990
AS - Asia 8.679
EU - Europa 8.375
SA - Sud America 1.138
AF - Africa 156
Continente sconosciuto - Info sul continente non disponibili 40
OC - Oceania 22
Totale 37.400
Nazione #
US - Stati Uniti d'America 18.851
SG - Singapore 3.131
CN - Cina 2.075
PL - Polonia 1.434
UA - Ucraina 1.376
SE - Svezia 1.263
IT - Italia 1.112
VN - Vietnam 902
BR - Brasile 893
HK - Hong Kong 839
KR - Corea 674
DE - Germania 544
FI - Finlandia 542
FR - Francia 515
TR - Turchia 455
GB - Regno Unito 384
RU - Federazione Russa 318
IE - Irlanda 243
BG - Bulgaria 229
IN - India 153
NL - Olanda 107
AR - Argentina 96
BD - Bangladesh 70
CA - Canada 65
ES - Italia 65
IQ - Iraq 54
MA - Marocco 46
MX - Messico 46
ID - Indonesia 44
JP - Giappone 44
EU - Europa 36
EC - Ecuador 31
BE - Belgio 30
PK - Pakistan 30
VE - Venezuela 30
AT - Austria 28
ZA - Sudafrica 28
CH - Svizzera 27
CL - Cile 26
RO - Romania 24
CO - Colombia 22
PH - Filippine 20
SA - Arabia Saudita 20
EG - Egitto 18
CZ - Repubblica Ceca 17
IR - Iran 17
KE - Kenya 17
PT - Portogallo 17
UZ - Uzbekistan 17
AU - Australia 16
PY - Paraguay 15
MT - Malta 14
IL - Israele 13
JO - Giordania 12
TH - Thailandia 12
DK - Danimarca 11
DZ - Algeria 11
PE - Perù 11
SN - Senegal 11
AZ - Azerbaigian 10
HR - Croazia 10
LT - Lituania 10
HU - Ungheria 9
NP - Nepal 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
KZ - Kazakistan 8
MY - Malesia 8
BA - Bosnia-Erzegovina 7
KG - Kirghizistan 7
LB - Libano 7
AM - Armenia 6
CR - Costa Rica 6
LV - Lettonia 6
OM - Oman 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
GR - Grecia 5
JM - Giamaica 5
LK - Sri Lanka 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
AL - Albania 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
EE - Estonia 4
MN - Mongolia 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
KW - Kuwait 3
LY - Libia 3
PS - Palestinian Territory 3
QA - Qatar 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
CY - Cipro 2
ET - Etiopia 2
GA - Gabon 2
Totale 37.370
Città #
Woodbridge 2.131
Ann Arbor 1.847
Fairfield 1.786
Singapore 1.772
Houston 1.678
Ashburn 1.524
Jacksonville 1.207
Warsaw 1.178
Chandler 987
Wilmington 877
Hong Kong 805
Seattle 775
San Jose 744
Seoul 664
Cambridge 610
Hefei 585
Beijing 456
Princeton 448
Boardman 414
Izmir 381
Chicago 280
Ho Chi Minh City 253
Dublin 243
Columbus 225
Lauterbourg 222
Sofia 222
Trieste 217
Zgierz 216
Hanoi 214
Dallas 212
Los Angeles 180
The Dalles 175
Moscow 174
Buffalo 163
Düsseldorf 131
Milan 123
Dearborn 120
Frankfurt am Main 109
Helsinki 104
São Paulo 93
Munich 89
San Diego 89
Santa Clara 85
Bremen 82
London 68
Verona 61
New York 53
Council Bluffs 52
Da Nang 51
Guangzhou 49
Haiphong 44
Turku 38
Nanjing 37
Des Moines 36
Tianjin 36
Jinan 35
Sacile 35
Tokyo 35
Casablanca 34
Brussels 28
Chennai 28
Orem 28
Kunming 27
Shanghai 27
Falls Church 25
Nuremberg 25
Hangzhou 24
Mestre 24
Fremont 23
Phoenix 23
Redondo Beach 23
Dong Ket 22
Toronto 22
Norwalk 21
Rome 21
Washington 21
Ankara 20
Poplar 20
Rio de Janeiro 20
Baghdad 19
Brooklyn 19
Montreal 19
Brasília 18
Curitiba 18
Pune 18
Stockholm 18
Atlanta 17
Bern 17
Boston 17
Tashkent 17
Wroclaw 17
Barnet 16
Biên Hòa 16
Campinas 16
Dhaka 16
Mumbai 16
San Francisco 16
Zhengzhou 16
Amsterdam 15
Belo Horizonte 15
Totale 26.382
Nome #
Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease 480
Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy 376
Combined Analysis of Methylation and Gene Expression Profiles in Separate Compartments of Small Bowel Mucosa Identified Celiac Disease Patients’ Signatures 345
Cross-sectional study of coeliac autoimmunity in a population of Vietnamese children 344
Electrochemical Immunosensor Based on Nanoelectrode Ensembles for the Serological Analysis of IgG-type Tissue Transglutaminase 331
Changing Epidemiology of Liver Involvement in Children with Celiac Disease 330
Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction 323
Anti-transglutaminase antibodies and age. 297
Anti transglutaminase antibodies cause ataxia in mice. 291
A reliable screening procedure for coeliac disease in clinical practice. 289
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. 288
Diagnostic accuracy and applicability of intestinal auto-antibodies in the wide clinical spectrum of coeliac disease 285
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 284
Intestinal production of anti-tissue transglutaminase 2 antibodies in patients with diagnosis other than celiac disease 283
Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction 280
A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis 274
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 272
Anti-transglutaminase 6 antibody development in children with celiac disease correlates with duration of gluten exposure 269
Diagnostic Delays in Children with Coeliac Disease in the Central European Region 259
Variant mannose-binding lectin alleles are associated with celiac disease 255
Potential use of MCR-ALS for the identification of coeliac-related biochemical changes in hyperspectral Raman maps from pediatric intestinal biopsies 252
Tag-single nucleotide polymorphism-based human leukocyte antigen genotyping in celiac disease patients from northeastern Italy 250
Immunohistologic analysis of the duodenal bulb: a new method for celiac disease diagnosis in children 250
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 249
Serum Anti-Tissue Transglutaminase Antibodies Detected during Febrile Illness May Not Be Produced by the Intestinal Mucosa 249
Coeliac disease in the ERA of the new ESPGHAN and BSPGHAN guidelines: a prospective cohort study 249
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 249
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 244
Innate and adaptive immunity in self-reported nonceliac gluten sensitivity versus celiac disease 243
The humoral response in the pathogenesis of gluten ataxia 242
Autoantibodies as predictors of disease. 236
The Use of Biopsy and "no-Biopsy" Approach for Diagnosing Paediatric Coeliac Disease in the Central European Region 234
Regulatory T-Cell Function Is Impaired in Celiac Disease. 229
The gut as site of production of autoimmune antibodies. 228
Dual sugar gut-permeability testing on blood drop in animal models. 226
A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies 226
Clinical Presentation in Children With Coeliac Disease in Central Europe 223
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 223
Molecular dissection of the tissue transglutaminase auto-antibody response in celiac disease 221
Prevalence of celiac disease in patients with severe food allergy 221
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. 218
Anti-transglutaminase and age, Clinical Chemestry 215
Evaluation of gut-vascular barrier by plasmalemma vesicle-associated protein-1 measurements in patients with celiac disease and abnormal serum alanine transaminase 214
A Sensitive Electrochemiluminescence Immunosensor for Celiac Disease Diagnosis Based on Nanoelectrode Ensembles 213
The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency 211
Ages of celiac disease: from changing environment to improved diagnostics 210
Sedation with intranasal midazolam of Angolan children undergoing invasive procedures. 209
Anti-idiotypic response in mice expressing human autoantibodies. 208
Anti tTG autoantibodies crossreacting with brain structures are produced in the intestine in celiac patient with equilibrium disorder 208
Association study of the IL18RAP locus in three European populations with coeliac disease 208
Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations 206
Anti-alpha enolase autoantibodies in coeliac disease 206
Anti-brain but not celiac disease antibodies in Landau-Kleffner Syndrome and related epilepsies. 204
Anti-α-enolase Antibodies in Serum from Pediatric Patients Affected by Inflammatory Diseases: Diagnostic and Pathogenetic Insights. 204
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 203
Antibodies to transglutaminasefrom phage display libraries 201
A population based seroepidemiological survey of Chlamydia pneumoniaeinfections in schoolchildren. 200
Alterations in zonulinsecretion precedes the onset of diabetes in BB/Wor rats 200
Development of a novel rapid non-invasive screening test for coeliac disease. 196
Speeding up coeliac disease diagnosis in cardiological settings 196
A new, rapid, noninvasive screening test for celiac disease. 193
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 192
Zonulin is involved in the impairment of the gut barrier function following small intestinal bacterial colonization 190
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 190
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. 189
Humoral response in the pathogenesis of gluten ataxia 189
Digital Radiology to Improve the Quality of Care in Countries with Limited Resources: A Feasibility Study from Angola 189
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 188
Sensitivity and specificity of simple and rapid commercial assays for the diagnosis of coeliac disease 188
Gastrointestinal Foxp3 expression in normal, inflammatory and neoplastic conditions 188
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases 187
Strip AGA test: a rapid and accurate method in screening for coeliac disease 184
Abdominal presentation ofcat acratch disease: is a biopsy always necessary? 182
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 181
Protective role of anti-idiotypic network in celiac disease prone subjects 181
The microsnapwell system: a new in vitro polarized model for studying the intestinal barrier functions using small intestinal biopsy specimens 178
Compliance with the gluten-free diet: the role of locus of control in celiac disease 177
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 176
Management of coeliac disease patients after the confirmation of diagnosis in Central Europe 176
Alterations in zonulin secretion parallels changes in intestinal permeability and precede the onset of diabetes in BB/Wor diabetic rats 175
Charecterization of tissue transglutaminase auto-antigenic response using cloned structural domains 174
Celiac Disease Frequency Is Increased in IgE-Mediated Food Allergy and Could Affect Allergy Severity and Resolution 173
Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes. 173
Prevalence of celiac disease among risk groups and the general population in USA 172
Gluten dependent diabetes-related and thyroid-related autoantibodies in coeliac patients: a prospective study. 171
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 170
Role of zonulin in the intestinal permeability changes typical of the acute phase of coeliac disease 170
Screening ofcoeliac disease in helthy blood donors from two immunotransfusionalcenters in nothest Italy 169
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 169
Protective role of anti-idiotypic network in celiac disease prone subjects 167
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 166
Autoinflammatory syndromes and coeliac disease: One observation and two hypotheses 166
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 164
Rapid Genetic Screening for major HLA risk haplotypes in patients with type 1 diabetes from North East Brazil 164
Role of zonulin in the intestinal permeability changes typical of the acute phase of coeliac disease. 163
Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease. 163
Speeding up coeliac disease diagnosis in the developing countries 162
Rapid characterization of VH-5 family specific anti-tTG intestinal antibodies in celiac and autoimmune patients 162
Coeliac disease in primary care: evaluation of a case-finding strategy 161
Spectroscopic investigation of faeces with surface-enhanced Raman scattering: a case study with coeliac patients on gluten-free diet 161
Totale 22.062
Categoria #
all - tutte 105.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.205


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021826 0 0 0 0 0 0 0 0 0 407 91 328
2021/20222.367 108 198 110 269 84 181 95 84 296 233 217 492
2022/20233.145 361 379 234 396 362 561 16 269 377 19 108 63
2023/20241.818 114 120 80 118 199 139 314 351 41 33 147 162
2024/20253.986 43 163 293 391 423 345 305 215 528 425 354 501
2025/20269.847 808 667 1.059 1.070 872 1.108 1.496 437 1.197 1.133 0 0
Totale 37.885